Skip to main content

Published locations for Subgroup may benefit from seribantumab for platinum-resistant ovarian cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Subgroup may benefit from seribantumab for platinum-resistant ovarian cancer

User login

  • Reset your password
  • /content/subgroup-may-benefit-seribantumab-platinum-resistant-ovarian-cancer
  • /obgynnews/article/116281/gynecologic-cancer/subgroup-may-benefit-seribantumab-platinum-resistant
  • /oncologypractice/article/116281/gynecologic-cancer/subgroup-may-benefit-seribantumab-platinum
  • /obgyn/article/116281/gynecologic-cancer/subgroup-may-benefit-seribantumab-platinum-resistant-ovarian
  • /hematology-oncology/article/116281/gynecologic-cancer/subgroup-may-benefit-seribantumab-platinum